Abstract

Ophthalmologists should consider interpreting fluorescein angiographic images of subfoveal lesions with terms provided to follow recommendations regarding which patients are most likely to benefit from verteporfin therapy based on results from the TAP Investigation and VIP Trial.

Keywords

VerteporfinMedicineChoroidal neovascularizationMacular degenerationFluorescein angiographyOphthalmologyVisual acuityPhotodynamic therapyLesionSurgery

MeSH Terms

Choroidal NeovascularizationFluorescein AngiographyFovea CentralisHumansMacular DegenerationMyopiaPhotochemotherapyPhotographyPhotosensitizing AgentsPorphyrinsProspective StudiesRandomized Controlled Trials as TopicTreatment OutcomeVerteporfinVisual Acuity

Affiliated Institutions

Related Publications

Publication Info

Year
2003
Type
article
Volume
121
Issue
9
Pages
1253-1253
Citations
210
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

210
OpenAlex
2
Influential
147
CrossRef

Cite This

Irene Barbazetto, Amy Burdan, Neil M. Bressler et al. (2003). Photodynamic Therapy of Subfoveal Choroidal Neovascularization With Verteporfin. Archives of Ophthalmology , 121 (9) , 1253-1253. https://doi.org/10.1001/archopht.121.9.1253

Identifiers

DOI
10.1001/archopht.121.9.1253
PMID
12963608

Data Quality

Data completeness: 86%